Reactive plasmacytosis is a rare finding that can obscure the underlying etiological disease, leading to misdiagnosis and inappropriate therapy. Here, we report a case of angioimmunoblastic T cell lymphoma that is represented by a striking amount of reactive plasmacytosis-expressing variable CD138 molecule (Fig. 1) .
plasmic Ig light chain restriction; positivity for CD45, CD27, and CD19; and negativity to CD56. DNA cell cycle analysis showed S-phase fraction that stained positive with CD38 and not with CD138, suggesting mitotic activity preferentially by the immature plasmablasts. Analysis of bone marrow (BM) aspirate by flow cytometry showed 20 % PCs and 10 % mature B cells, both with no Ig light chain restriction. IGH gene rearrangement that was performed in the BM aspirate showed clonal D H -J H peak with polyclonal background. BM T cells accounted for 8.5 % of total cells and comprised by 87 % CD4+ cells and 10 % CD8 cells. Tissue crumbs and cell wash from a core biopsy that was taken from the patient's inguinal lymph node showed 15 % PCs and few B cells, both with no Ig light chain restriction. IGH rearrangement that performed in the nodal specimen determined as polyclonal. T lymphocytes accounted for 60 % of total cells, comprising of 90 % CD4+ cells and 10 % CD8 cells. In addition, we observed a distinct subset (5 % of total cells) of CD45+/ FSC high /CD30 + /CD15 +/− /CD20 − /CD138 − cells that were suspected to be Hodgkin-Reed-Sternberg (HRS)-like cells.
Immunohistopathological assessment of the BM confirmed the striking amount of infiltrating PCs which evaluated to be around 30-40 % of the hematopoietic space cellular compartment as detected by CD138. Morphological assessment of the lymph node showed effaced follicular architecture, increased numbers of arborizing high endothelial venules, and atypical lymphocytes with a different size. Immunohistochemical staining showed predominancy of T cells (CD3+/CD5+), and the majority of them were CD4+. In addition, we found the appearance of 3-5 % of HRS-like cells that were characterized by LCA+/CD20+/CD30+/CD15
− . The HRS-like cells were negative to EBV. Finally, follicular dendritic cell proliferation was confirmed by CD21 positivity which together with clonal T TCRB and TCRG rearrangement suggested the diagnosis of T cell lymphoma, most probably the angioimmunoblastic subtype (AITL).
Reactive plasmacytosis was previously defined as an expansion of plasmablasts retaining the capacity to differentiate into plasma cells [2] . Although reactive plasmacytosis has been described in different reactive and malignant conditions [1, 4] , the relative amount of reactive PCs that we found in our case (20 % in PB and 30-40 % in BM) is remarkable. We assume that the pattern of variable CD138 expression we found in our case represents a spectrum of PCs with different maturation stages. The possibility that this variable CD138 represents loss of expression in apoptotic PCs seems unlikely as we did not detect an increase of apoptotic cells by the sub G0-G1 area of the DNA analysis we performed. Among the different immunophenotyping characteristics of the PCs, the non-restricted cytoplasmic Igs demonstrated was the most useful tool for determining reactive plasmacytosis in our case. In our case, we detected clonal IgH rearrangement in the BM and polyclonal IgH rearrangement in the nodal specimen. Clonal IgH rearrangement was reported in up to 40 % of AITL cases and suggested to be the result of the B cell expansion observed in the disease [1] . Accordingly, the clonal IgH rearrangement in the BM may be explained by the massive plasmablasts expansion at this site. Lack of equivalent clonal IgH rearrangement in the nodal specimen may be explained by the possibility that the plasmablasts are less expended at this site. However, we also could not exclude the possibility that this inconsistency resulted from the poor quality of the nodal specimen.
HRS-like cells with a background of plasma cells were previously described in the context of T cell lymphomas [3] . The immunophenotypic findings of HRS-like cells in these cases demonstrated strong CD30 staining, focal positivity to CD15, and variable immunoreactivity to CD20. The finding of CD30+ cells suspected as HRS-like cells in our case by flow cytometry is currently anecdotal, and further characterizing these cells in other cases is needed to verify their diagnostic utilization.
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